体外受精（IVF）市場 – 2029年までの世界予測

Report Overview

The global in vitro fertilization market is projected to reach USD 1,650 million by 2029 from USD  949 million in 2024, growing at a CAGR of 11.7% during the forecast period.

世界の体外受精（IVF）市場は、2024年の9億4,900万米ドルから2029年までに16億5,000万米ドルに達すると予測されており、予測期間中に11.7%のCAGRで成長します。

The projected market growth for in vitro fertilization is supported by the convergence of benefits. In Vitro Fertilization convergence of advantages supports the projected market growth of this industry. In vitro fertilization: A host of factors drives the demand, from improvements in assisted reproductive technologies improving treatment efficacy to expanded fertility service coverage by healthcare and availability of specialized clinics with highly qualified professionals specialized in health reproduction issues. The restraints are the high cost of the procedure that may put treatment beyond the reach of too many people or even couples..

“IVF EquipmentsS to register largest market share in 2022-2029.”

The kinds of equipment that are essential to dispensation of IVF treatment and their development for its success. In a nutshell, IVF mainly relies upon specialized tools such as embryo culture incubators, micromanipulators used for ICSI, and the cryopreservation systems used in the storage of embryos and gametes. Advanced imaging technologies allow for time-lapse imaging in the selection of viable embryos, and next-generation sequencing tools in the field of genetic screening improve embryo quality assessment. Together with advances in medical technology, IVF equipment is undergoing innovation. Such innovative research is institutionalized and underpinned by larger industrial initiatives that continue to drive success rates and overall patient outcomes. From the regulatory standards ensuring safety and effectiveness, to the healthcare policies increasing coverage for infertility treatments, and the highest role in making IVF equipment available worldwide, these combine to drive technological evolution and put the newest innovations in reproductive solutions before more and more people in need of fertility assistance..

“Fertility Clinics & IVF Centres segment held the largest share of in vitro fertilization market in 2023, by End-user.”

Based on the end-user, the in vitro fertilization market is segmented into fertility clinics & IVF centres, hospitals, surgical centers, and cryobanks. In the year 2023, the global in vitro fertilization market was dominated by hospitals and clinics. The growth of the hospital & clinic segment is getting accelerated.

By speeding up the problems of infertility, increasing IVF procedures for early detection of possible complications, and introducing continuous advanced technologies.

“Fresh non donor to register highest growth rate in the market during the forecast period.”

By Cycle Fresh Donor, Frozen Donor, Frozen Non Donor, Fresh Non Donor. Fresh non-donor is likely to grow at the fastest rate in the period from 2024-2029. Geographically On the basis of several leading and niche products, the market has been expounded,, and. with All the Reason the Market Seeing So Many Inexperienced Joiners without a Donor Vehicle. Whereas before, high entry barriers were powered by technologies and broad availability, which let people get involved in these app-based schemes without experience or donor vehicles..

“Asia Pacific to register highest growth rate in the market during the forecast period.”

The highest CAGR is likely to be registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific is made up of India, China, Japan, South Korea, Australia, and RoAPAC. The Asia-Pacific region has reflected the highest upsurge in the market growth rate for in vitro fertilization.

The majority of the share of in vitro fertilization (IVF) markets in the Asia-Pacific are top for a number of indispensable reasons With a number of important considerations countries in the Asia Pacific region now own the highest share of the in vitro fertilization market. First and foremost, IVF service needs have increased due to rising rates of infertility, commonality in delayed childbearing, and changes in lifestyle. Better infrastructural facilities in healthcare, rising disposable incomes, and increasing awareness about fertility treatments are making more countries across this region accept and procure IVF. Added to these is the development of reproductive technologies and government programs encouraging fertility treatments, which support the growth of the Asia Pacific industry.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level– 10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe-30%, Asia Pacific–22%, Rest of the world-8%

Prominent players in this market are Cooper companies inc.(US), Cook Medical Inc.(US),Vitrolife(Europe), Fujifilm Irvine scientific(Japan),Hamilton thorne ltd.(US), Thermo fisher scientific(US), Nikon corporation(Japan), Olympus(Japan), Kitazato corporation(Japan), Corning incorporated(US), Zeiss group(Europe), Fertipro nv(Europe), Eppendorf(Europe) among others.

Research Coverage

The segmentation is based on products, cycle, procedure, end user, and region. The report analyzes the factors that have been affecting and will affect the growth of the market, including drivers, restraints, opportunities, and challenges. The report details opportunities and challenges in the in vitro fertilization market for stakeholders. Further details on competitive landscapes for market leaders are also provided. This report evaluates micro-markets with respect to the growth trends, prospects, and contributions towards the global in vitro fertilization market. The report expects the revenues of the segments of the market to increase with a view of five major regions.

Key Benefits of Buying the Report:

• The report intends to help new entrants, it addresses the availability of comprehensive data to help new entrants, top players of the in vitro fertilization market, and small enterprises understand investment viability. It shall aid processes of robust risk assessment and which investment decisions. It offers precise segmentation of markets, like that based on end-users and regional dimensions, hence giving targeted segments tailored insights. It also evaluates the highest trends, challenges, growth drivers, and opportunities for the same, thereby empowering strategic decision-making with insightful judgment.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the in vitro fertilization market: Advanced technology and ageing population of women; high cost of IVF procedures and ethical concerns; growing number of fertility clinics and increased treatment option.They have declined infertility treatment among women of high age.

Product Development/Innovation: Insights into pipeline technologies, research & development activities, and new product & service launches in the in vitro fertilization market.

Market Development: Detailed information about lucrative markets—the report analyses the in vitro fertilization market across varied regions.

Market Diversification: Detailed insight into new products, untapped geographies, recent developments, and investments in the in vitro fertilization market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as CooperSurgical Inc.(US), Vitrolife (Sweden), Cook Medical Inc.(US), Hamilton Thorne (US) and Thermo Fisher Scientific(US) among others.

Table of Contents

1            INTRODUCTION            26

1.1         STUDY OBJECTIVES      26

1.2         MARKET DEFINITION   26

1.2.1      INCLUSIONS AND EXCLUSIONS 27

1.3         STUDY SCOPE  28

1.3.1      SEGMENTS COVERED   28

1.3.2      YEARS CONSIDERED     29

1.3.3      CURRENCY CONSIDERED          29

1.4         STAKEHOLDERS            29

1.5         SUMMARY OF CHANGES            30

2            RESEARCH METHODOLOGY     31

2.1         RESEARCH DATA           31

2.2         RESEARCH DESIGN       31

2.2.1      SECONDARY RESEARCH             32

2.2.1.1   Key data from secondary sources     33

2.2.2      PRIMARY RESEARCH     34

2.2.2.1   Primary sources   34

2.2.2.2   Key industry insights          35

2.2.2.3   Breakdown of primary interviews     35

2.3         MARKET SIZE ESTIMATION       36

2.3.1      BOTTOM-UP APPROACH           37

2.3.1.1   Company revenue estimation approach         38

2.3.1.2   Customer-based market estimation  38

2.3.1.3   Growth forecast approach  39

2.3.1.4   CAGR projections             40

2.4         DATA TRIANGULATION             41

2.5         MARKET SHARE ASSESSMENT   42

2.6         RESEARCH ASSUMPTIONS         42

2.7         GROWTH RATE ASSUMPTIONS 42

2.8         RESEARCH LIMITATIONS           44

2.9         RISK ASSESSMENT         44

3            EXECUTIVE SUMMARY 45

4            PREMIUM INSIGHTS      48

4.1         IN VITRO FERTILIZATION MARKET OVERVIEW 48

4.2         IN VITRO FERTILIZATION MARKET, BY REGION             49

4.3         ASIA PACIFIC IN VITRO FERTILIZATION MARKET, BY COUNTRY AND END USER, 2023 50

4.4         GEOGRAPHIC SNAPSHOT OF IN VITRO FERTILIZATION MARKET              51

5            MARKET OVERVIEW     52

5.1         INTRODUCTION            52

5.2         MARKET DYNAMICS     53

5.2.1      DRIVERS            53

5.2.1.1   Increasing median age of pregnancy 53

5.2.1.2   Rising infertility rate          54

5.2.1.3   Booming fertility industry  55

5.2.1.4   Evolving technological landscape     56

5.2.1.5   Favorable government initiatives     58

5.2.2      RESTRAINTS     59

5.2.2.1   High cost of IVF procedures            59

5.2.2.2   Social and ethical concerns in developing countries      60

5.2.2.3   Elevated risk of complications          60

5.2.3      OPPORTUNITIES           61

5.2.3.1   Growth opportunities in emerging economies 61

5.2.3.2   Availability of diverse range of fertility treatment options           61

5.2.4      CHALLENGES   62

5.2.4.1   Reduced efficacy of infertility treatments for patients of advanced age     62

5.3         VALUE CHAIN ANALYSIS            62

5.3.1      RESEARCH & DEVELOPMENT   63

5.3.2      RAW MATERIAL PROCUREMENT AND MANUFACTURING          63

5.3.3      MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES              63

5.4         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65

5.5         PRICING ANALYSIS        66

5.5.1      AVERAGE SELLING PRICE TREND, BY REGION  66

5.5.2      AVERAGE SELLING PRICE TREND OF TOP 3 ACCESSORIES, BY KEY PLAYER 68

5.6         PORTER’S FIVE FORCES ANALYSIS         69

5.6.1      THREAT OF NEW ENTRANTS    70

5.6.2      THREAT OF SUBSTITUTES         70

5.6.3      BARGAINING POWER OF SUPPLIERS     70

5.6.4      BARGAINING POWER OF BUYERS           70

5.6.5      INTENSITY OF COMPETITIVE RIVALRY 70

5.7         PATENT ANALYSIS        71

5.8         TRADE DATA ANALYSIS             74

5.8.1      IMPORT DATA 74

5.8.2      EXPORT DATA 75

5.9         KEY CONFERENCES AND EVENTS, 2024–2025     75

5.10       KEY STAKEHOLDERS AND BUYING CRITERIA    77

5.10.1    KEY STAKEHOLDERS IN BUYING PROCESS         77

5.10.2    BUYING CRITERIA         78

5.11       UNMET NEEDS 79

5.12       ECOSYSTEM ANALYSIS 80

5.13       SUPPLY CHAIN ANALYSIS          81

5.13.1    PROMINENT COMPANIES          81

5.13.2    SMALL AND MEDIUM-SIZED ENTERPRISES        81

5.13.3    END USERS       81

5.14       TECHNOLOGY ANALYSIS           82

5.14.1    KEY TECHNOLOGIES    82

5.14.1.1 Time-lapse technology      82

5.14.2    COMPLEMENTARY TECHNOLOGIES     83

5.14.2.1 Preimplantation genetic testing        83

5.14.3    ADJACENT TECHNOLOGIES      83

5.14.3.1 Sperm cryopreservation     83

5.14.3.2 Oocyte cryopreservation    83

5.15       CASE STUDY ANALYSIS 84

5.15.1    ENHANCED IVF RATES USING EMBRYOTOXICITY, PLATELET LEUKOCYTE AGGREGATES, AND NATURAL KILLER DIAGNOSIS             84

5.16       REGULATORY LANDSCAPE       85

5.16.1    REGULATORY STANDARDS AND APPROVALS   85

5.16.1.1 North America     85

5.16.1.1.1            US         85

5.16.1.1.2            Canada  86

5.16.1.2 Europe  86

5.16.1.3 Asia Pacific          86

5.16.1.3.1            India      86

5.16.1.3.2            Japan     86

5.16.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          87

5.17       INVESTMENT AND FUNDING SCENARIO            90

5.18       REIMBURSEMENT SCENARIO    91

5.19       IMPACT OF GEN AI ON IN VITRO FERTILIZATION MARKET       92

6            IN VITRO FERTILIZATION MARKET, BY PRODUCT         93

6.1         INTRODUCTION            94

6.2         EQUIPMENT     95

6.2.1      MICROSCOPES 96

6.2.1.1   Need for assessing cell division and morphology during embryo development to drive market        96

6.2.2      IMAGING SYSTEMS       97

6.2.2.1   Need for real-time monitoring of oocytes and embryos to fuel market      97

6.2.3      SPERM ANALYZER SYSTEMS      98

6.2.3.1   Capability to identify fertility problems and determine appropriate interventions to fuel market      98

6.2.4      OVUM ASPIRATION PUMPS       99

6.2.4.1   Optimized retrieval of viable eggs and shortened procedure duration to aid growth              99

6.2.5      MICROMANIPULATOR SYSTEMS            100

6.2.5.1   Increased adoption in intracytoplasmic sperm injections and embryo biopsies to boost market        100

6.2.6      INCUBATORS    101

6.2.6.1   Time-lapse incubators       102

6.2.6.1.1 Non-invasive techniques to propel market     102

6.2.6.2   Other incubators 103

6.2.7      GAS ANALYZERS            103

6.2.7.1   Ability to replicate natural conditions of human reproductive system to drive market   103

6.2.8      CRYOSYSTEMS 104

6.2.8.1   Higher flexibility to use stored embryos, sperm, and eggs to support market growth              104

6.2.9      LASER SYSTEMS             105

6.2.9.1   Precise embryo manipulation and observation to augment growth           105

6.2.10    SPERM SEPARATION SYSTEMS  105

6.2.10.1 Need to maintain stable and optimal conditions in controlled environment to stimulate segment growth  105

6.2.11    CABINETS         106

6.2.11.1 Rising awareness about biological safety of IVF to boost market 106

6.2.12    ANTI-VIBRATION TABLES          107

6.2.12.1 Growing need for improved procedural accuracy to fuel market 107

6.2.13    WITNESS SYSTEMS        108

6.2.13.1 Rigorous safety and quality assurance standards to stimulate growth        108

6.2.14    OTHER EQUIPMENT     108

6.3         REAGENTS & MEDIA     109

6.3.1      EMBRYO CULTURE MEDIA        110

6.3.1.1   Enhanced health and viability during embryo culture to aid growth          110

6.3.2      CRYOPRESERVATION MEDIA    110

6.3.2.1   Ability to protect cells from damage to drive market     110

6.3.3      SPERM PROCESSING MEDIA      111

6.3.3.1   Use in washing, capacitation, and sperm selection applications to boost segment              111

6.3.4      OVUM PROCESSING MEDIA      112

6.3.4.1   Ability to mimic natural conditions of female reproductive tract to propel market              112

6.4         ACCESSORIES   112

6.4.1      GROWING INCLINATION TOWARD COMFORTABLE IVF PROCEDURE TO SUPPORT GROWTH 112

7            IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE             114

7.1         INTRODUCTION            115

7.2         FRESH NON-DONORS   116

7.2.1      RISING PREFERENCE FOR TREATMENT AMONG YOUNGER WOMEN TO AUGMENT GROWTH            116

7.3         FROZEN NON-DONORS 116

7.3.1      IMPROVED EGG QUALITY AND FLEXIBLE SCHEDULING TO BOOST MARKET            116

7.4         FROZEN DONORS          117

7.4.1      GROWING INCLINATION TOWARD READY-TO-USE HEALTHY EGGS TO FUEL MARKET         117

7.5         FRESH DONORS             118

7.5.1      HIGHER CHANCE OF FERTILIZATION AND EMBRYO DEVELOPMENT TO PROPEL MARKET    118

8            IN VITRO FERTILIZATION MARKET, BY PROCEDURE     119

8.1         INTRODUCTION            120

8.2         CONVENTIONAL IVF     120

8.2.1      PROVEN SUCCESS RATE IN ADDRESSING INFERTILITY ISSUES TO DRIVE MARKET 120

8.3         IVF WITH INTRACYTOPLASMIC SPERM INJECTIONS      121

8.3.1      HIGHER SUCCESS RATES THAN CONVENTIONAL METHODS TO STIMULATE GROWTH  121

8.4         MINIMAL IVF    122

8.4.1      RISING EMPHASIS ON MINIMIZED POTENTIAL SIDE EFFECTS TO SUPPORT MARKET        122

8.5         IVF WITH DONOR EGGS             123

8.5.1      ABILITY TO ADDRESS PREMATURE OVARIAN FAILURE OR GENETIC DISORDERS TO AUGMENT GROWTH    123

8.6         OTHER PROCEDURES   124

9            IN VITRO FERTILIZATION MARKET, BY END USER          125

9.1         INTRODUCTION            126

9.2         FERTILITY CLINICS & IVF CENTERS       126

9.2.1      INCREASED AVAILABILITY AND ACCESSIBILITY TO FUEL MARKET              126

9.3         HOSPITALS & SURGICAL CENTERS        127

9.3.1      NEED FOR ADVANCED LABORATORIES FOR GAMETE HANDLING AND ULTRASOUND MONITORING TO FUEL MARKET            127

9.4         RESEARCH INSTITUTES             128

9.4.1      ONGOING RESEARCH FOR COST-EFFECTIVE AND ADVANCED TECHNIQUES TO BOOST MARKET         128

9.5         CRYOBANKS     129

9.5.1      GROWING INCLINATION TOWARD FLEXIBLE TREATMENT TO AID MARKET GROWTH        129

10          IN VITRO FERTILIZATION MARKET, BY REGION             131

10.1       INTRODUCTION            132

10.2       ASIA PACIFIC    132

10.2.1    CHINA  138

10.2.1.1 Increasing medical benefits for childbirth to drive market          138

10.2.2    JAPAN  140

10.2.2.1 Low fertility rates to support market growth  140

10.2.3    INDIA   142

10.2.3.1 Affordable treatment options to fuel market   142

10.2.4    AUSTRALIA       144

10.2.4.1 Declining fertility rate to propel market         144

10.2.5    SOUTH KOREA 146

10.2.5.1 Growing focus on reversing low population trend to stimulate growth      146

10.2.6    REST OF ASIA PACIFIC  148

10.3       EUROPE             151

10.3.1    GERMANY         155

10.3.1.1 Robust healthcare infrastructure to support market growth        155

10.3.2    UK         157

10.3.2.1 Growing focus on high-quality care at licensed fertility clinics to propel market              157

10.3.3    FRANCE             159

10.3.3.1 Rising age of women at first birth to boost market        159

10.3.4    ITALY   161

10.3.4.1 Regulatory guidelines to govern market         161

10.3.5    SPAIN   163

10.3.5.1 Booming medical tourism to drive market      163

10.3.6    REST OF EUROPE           165

10.4       NORTH AMERICA          167

10.4.1    US         171

10.4.1.1 Favorable infrastructure network to drive market         171

10.4.2    CANADA            173

10.4.2.1 Growing assistance from banks for fertility treatments to fuel market       173

10.5       LATIN AMERICA             176

10.5.1    BRAZIL 180

10.5.1.1 Decrease in percentage of women under 30 years of age to stimulate growth              180

10.5.2    MEXICO             183

10.5.2.1 Growing network of state-of-the-art facilities to aid market growth          183

10.5.3    REST OF LATIN AMERICA          185

10.6       MIDDLE EAST & AFRICA             188

10.6.1    GCC COUNTRIES           192

10.6.1.1 Improving health infrastructure and better awareness about fertility treatments to propel market      192

10.6.2    REST OF MIDDLE EAST & AFRICA           195

11          COMPETITIVE LANDSCAPE       197

11.1       OVERVIEW        197

11.2       KEY PLAYER STRATEGY/RIGHT TO WIN             197

11.2.1    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN IN VITRO FERTILIZATION MARKET           198

11.3       REVENUE ANALYSIS      199

11.4       MARKET SHARE ANALYSIS         200

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   202

11.5.1    STARS  202

11.5.2    EMERGING LEADERS    202

11.5.3    PERVASIVE PLAYERS     202

11.5.4    PARTICIPANTS 202

11.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      204

11.5.5.1 Company footprint            204

11.5.5.2 Product footprint 205

11.5.5.3 End-user footprint             206

11.5.5.4 Region footprint  207

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          208

11.6.1    PROGRESSIVE COMPANIES       208

11.6.2    RESPONSIVE COMPANIES          208

11.6.3    DYNAMIC COMPANIES 208

11.6.4    STARTING BLOCKS       208

11.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             210

11.7       COMPANY VALUATION AND FINANCIAL METRICS        212

11.7.1    FINANCIAL METRICS    212

11.7.2    COMPANY VALUATION 212

11.8       BRAND/PRODUCT COMPARISON          213

11.9       COMPETITIVE SCENARIO          214

11.9.1    PRODUCT LAUNCHES AND APPROVALS            214

11.9.2    DEALS  214

12          COMPANY PROFILES    216

12.1       KEY PLAYERS   216

12.1.1    COOPERSURGICAL, INC.            216

12.1.1.1 Business overview 216

12.1.1.2 Products offered  217

12.1.1.3 Recent developments         218

12.1.1.3.1            Deals     218

12.1.1.4 MnM view           219

12.1.1.4.1            Right to win         219

12.1.1.4.2            Strategic choices  219

12.1.1.4.3            Weaknesses and competitive threats 219

12.1.2    VITROLIFE        220

12.1.2.1 Business overview 220

12.1.2.2 Products offered  221

12.1.2.3 Recent developments         222

12.1.2.3.1            Deals     222

12.1.2.4 MnM view           222

12.1.2.4.1            Right to win         222

12.1.2.4.2            Strategic choices  222

12.1.2.4.3            Weaknesses and competitive threats 223

12.1.3    COOK MEDICAL INC.    224

12.1.3.1 Business overview 224

12.1.3.2 Products offered  224

12.1.3.3 Recent developments         225

12.1.3.3.1            Product launches and approvals       225

12.1.3.3.2            Deals     225

12.1.3.4 MnM view           226

12.1.3.4.1            Right to win         226

12.1.3.4.2            Strategic choices  226

12.1.3.4.3            Weaknesses and competitive threats 226

12.1.4    HAMILTON THORNE    227

12.1.4.1 Business overview 227

12.1.4.2 Products offered  228

12.1.4.3 Recent developments         229

12.1.4.3.1            Deals     229

12.1.4.4 MnM view           230

12.1.4.4.1            Right to win         230

12.1.4.4.2            Strategic choices  230

12.1.4.4.3            Weaknesses and competitive threats 230

12.1.5    THERMO FISHER SCIENTIFIC INC.          231

12.1.5.1 Business overview 231

12.1.5.2 Products offered  232

12.1.5.3 MnM view           233

12.1.5.3.1            Right to win         233

12.1.5.3.2            Strategic choices  233

12.1.5.3.3            Weaknesses and competitive threats 233

12.1.6    FUJIFILM IRVINE SCIENTIFIC    234

12.1.6.1 Business overview 234

12.1.6.2 Products offered  235

12.1.6.3 Recent developments         236

12.1.6.3.1            Product launches and approvals       236

12.1.6.3.2            Other developments          236

12.1.7    KITAZATO CORPORATION        237

12.1.7.1 Business overview 237

12.1.7.2 Products offered  237

12.1.7.3 Recent developments         239

12.1.7.3.1            Deals     239

12.1.8    ESCO MICRO PTE. LTD. 240

12.1.8.1 Business overview 240

12.1.8.2 Products offered  240

12.1.8.3 Recent developments         242

12.1.8.3.1            Deals     242

12.1.9    FERTIPRO NV   243

12.1.9.1 Business overview 243

12.1.9.2 Products offered  243

12.1.10  GENEA BIOMEDX          245

12.1.10.1             Business overview 245

12.1.10.2             Products offered  245

12.1.10.3             Recent developments         246

12.1.10.3.1          Deals     246

12.1.11  NIKON CORPORATION 247

12.1.11.1             Business overview 247

12.1.11.2             Products offered  248

12.1.12  OLYMPUS          249

12.1.12.1             Business overview 249

12.1.12.2             Products offered  250

12.1.13  CORNING INCORPORATED       251

12.1.13.1             Business overview 251

12.1.13.2             Products offered  252

12.1.14  CARL ZEISS MICROSCOPY GMBH           253

12.1.14.1             Business overview 253

12.1.14.2             Products offered  254

12.1.15  EPPENDORF     255

12.1.15.1             Business overview 255

12.1.15.2             Products offered  256

12.1.15.3             Recent developments         256

12.1.15.3.1          Deals     256

12.1.16  MEIJI TECHNO 257

12.1.16.1             Business overview 257

12.1.16.2             Products offered  257

12.1.17  LEICA MICROSYSTEMS 258

12.1.17.1             Business overview 258

12.1.17.2             Products offered  258

12.1.18  GE HEALTHCARE          259

12.1.18.1             Business overview 259

12.1.18.2             Products offered  260

12.1.18.3             Recent developments         261

12.1.18.3.1          Product launches and approvals       261

12.1.18.3.2          Deals     261

12.2       OTHER COMPANIES      262

12.2.1    BIOIMAGER      262

12.2.2    ALLWIN MEDICAL DEVICES      263

12.2.3    SHANGHAI UNICORN MEDICAL TECHNOLOGY 263

12.2.4    GYNEMED         264

12.2.5    INVITROCARE  265

12.2.6    IVFTECH           266

12.2.7    LABIVF 267

12.2.8    MONASH BIOTECH       268

12.2.9    HUNTER SCIENTIFIC     268

12.2.10  CALIBRE SCIENTIFIC     269

12.2.11  SHIVANI SCIENTIFIC INDUSTRIES (P) LTD.        270

12.2.12  MINITUBE HUMAN ART              271

13          APPENDIX         272

13.1       DISCUSSION GUIDE      272

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             277

13.3       CUSTOMIZATION OPTIONS      279

13.4       RELATED REPORTS       279

13.5       AUTHOR DETAILS         280

LIST OF TABLES

TABLE 1             IN VITRO FERTILIZATION MARKET: INCLUSIONS AND EXCLUSIONS    27

TABLE 2             AVERAGE SELLING PRICE OF IVF EQUIPMENT, BY REGION, 2023 (USD THOUSAND) 66

TABLE 3             AVERAGE SELLING PRICES OF TOP 3 ACCESSORIES, BY KEY PLAYER, 2023 (USD)      68

TABLE 4             IN VITRO FERTILIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS          69

TABLE 5             INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024              72

TABLE 6             IMPORT DATA FOR HS CODE 902750, BY COUNTRY,

2019–2023 (USD THOUSAND)     74

TABLE 7             EXPORT DATA FOR HS CODE 902750, BY COUNTRY,

2019–2023 (USD THOUSAND)     75

TABLE 8             IN VITRO FERTILIZATION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025        75

TABLE 9             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR

TOP TWO END USERS (%)          77

TABLE 10           KEY BUYING CRITERIA, BY TOP TWO END USERS           78

TABLE 11           IN VITRO FERTILIZATION MARKET: CURRENT UNMET NEEDS              79

TABLE 12           IN VITRO FERTILIZATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM     81

TABLE 13           REGULATORY STANDARDS AND APPROVALS FOR IN VITRO FERTILIZATION,

BY COUNTRY    85

TABLE 14           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 87

TABLE 15           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 87

TABLE 16           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 88

TABLE 17           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 89

TABLE 18           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 89

TABLE 19           MAJOR CPT CODES FOR LASER PROCEDURES IN US, 2023              91

TABLE 20           IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 94

TABLE 21          IN VITRO FERTILIZATION EQUIPMENT MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          95

TABLE 22           IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY REGION,

2022–2029 (USD MILLION)          96

TABLE 23           IN VITRO FERTILIZATION MARKET FOR MICROSCOPES, BY REGION,

2022–2029 (USD MILLION)          97

TABLE 24           IN VITRO FERTILIZATION MARKET FOR IMAGING SYSTEMS, BY REGION,

2022–2029 (USD MILLION)          98

TABLE 25           IN VITRO FERTILIZATION MARKET FOR SPERM ANALYZER SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            99

TABLE 26           IN VITRO FERTILIZATION MARKET FOR OVUM ASPIRATION PUMPS, BY REGION, 2022–2029 (USD MILLION) 100

TABLE 27           IN VITRO FERTILIZATION MARKET FOR MICROMANIPULATOR SYSTEMS,

BY REGION, 2022–2029 (USD MILLION)  101

TABLE 28           IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          102

TABLE 29           IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY REGION,

2022–2029 (USD MILLION)          102

TABLE 30           IN VITRO FERTILIZATION MARKET FOR TIME-LAPSE INCUBATORS, BY REGION, 2022–2029 (USD MILLION)    103

TABLE 31           IN VITRO FERTILIZATION MARKET FOR OTHER INCUBATORS, BY REGION,

2022–2029 (USD MILLION)          103

TABLE 32           IN VITRO FERTILIZATION MARKET FOR GAS ANALYZERS, BY REGION,

2022–2029 (USD MILLION)          104

TABLE 33           IN VITRO FERTILIZATION MARKET FOR CRYOSYSTEMS, BY REGION,

2022–2029 (USD MILLION)          104

TABLE 34           IN VITRO FERTILIZATION MARKET FOR LASER SYSTEMS, BY REGION,

2022–2029 (USD MILLION)          105

TABLE 35           IN VITRO FERTILIZATION MARKET FOR SPERM SEPARATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)            106

TABLE 36          IN VITRO FERTILIZATION MARKET FOR CABINETS, BY REGION,

2022–2029 (USD MILLION)          107

TABLE 37           IN VITRO FERTILIZATION MARKET FOR ANTI-VIBRATION TABLES, BY REGION, 2022–2029 (USD MILLION) 107

TABLE 38           IN VITRO FERTILIZATION MARKET FOR WITNESS SYSTEMS, BY REGION,

2022–2029 (USD MILLION)          108

TABLE 39           IN VITRO FERTILIZATION MARKET FOR OTHER EQUIPMENT, BY REGION,

2022–2029 (USD MILLION)          109

TABLE 40           IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY REGION,

2022–2029 (USD MILLION)          109

TABLE 41           IN VITRO FERTILIZATION MARKET FOR EMBRYO CULTURE MEDIA, BY REGION, 2022–2029 (USD MILLION)  110

TABLE 42           IN VITRO FERTILIZATION MARKET FOR CRYOPRESERVATION MEDIA, BY REGION, 2022–2029 (USD MILLION)  111

TABLE 43           IN VITRO FERTILIZATION MARKET FOR SPERM PROCESSING MEDIA, BY REGION, 2022–2029 (USD MILLION)  111

TABLE 44           IN VITRO FERTILIZATION MARKET FOR OVUM PROCESSING MEDIA, BY REGION, 2022–2029 (USD MILLION)  112

TABLE 45           IN VITRO FERTILIZATION MARKET FOR ACCESSORIES, BY REGION,

2022–2029 (USD MILLION)          113

TABLE 46           COMPARISON BETWEEN FRESH AND FROZEN DONOR EGGS              115

TABLE 47           IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)     115

TABLE 48           IN VITRO FERTILIZATION MARKET FOR FRESH NON-DONORS, BY REGION,

2022–2029 (USD MILLION)          116

TABLE 49           IN VITRO FERTILIZATION MARKET FOR FROZEN NON-DONORS, BY REGION,

2022–2029 (USD MILLION)          117

TABLE 50           IN VITRO FERTILIZATION MARKET FOR FROZEN DONORS, BY REGION,

2022–2029 (USD MILLION)          118

TABLE 51           IN VITRO FERTILIZATION MARKET FOR FRESH DONORS, BY REGION,

2022–2029 (USD MILLION)          118

TABLE 52           IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION) 120

TABLE 53           IN VITRO FERTILIZATION MARKET FOR CONVENTIONAL IVF, BY REGION,

2022–2029 (USD MILLION)          121

TABLE 54           IN VITRO FERTILIZATION MARKET FOR IVF WITH INTRACYTOPLASMIC SPERM INJECTIONS, BY REGION, 2022–2029 (USD MILLION)          122

TABLE 55           IN VITRO FERTILIZATION MARKET FOR MINIMAL IVF, BY REGION,

2022–2029 (USD MILLION)          123

TABLE 56           IN VITRO FERTILIZATION MARKET FOR IVF WITH DONOR EGGS, BY REGION,

2022–2029 (USD MILLION)          124

TABLE 57           IN VITRO FERTILIZATION MARKET FOR OTHER PROCEDURES, BY REGION,

2022–2029 (USD MILLION)          124

TABLE 58           IN VITRO FERTILIZATION MARKET, BY END USER, 2022–2029 (USD MILLION) 126

TABLE 59           IN VITRO FERTILIZATION MARKET FOR FERTILITY CLINICS & IVF CENTERS,

BY REGION, 2022–2029 (USD MILLION)  127

TABLE 60           IN VITRO FERTILIZATION MARKET FOR HOSPITALS & SURGICAL CENTERS,

BY REGION, 2022–2029 (USD MILLION)  128

TABLE 61           IN VITRO FERTILIZATION MARKET FOR RESEARCH INSTITUTES, BY REGION,

2022–2029 (USD MILLION)          129

TABLE 62           IN VITRO FERTILIZATION MARKET FOR CRYOBANKS, BY REGION,

2022–2029 (USD MILLION)          130

TABLE 63           IN VITRO FERTILIZATION MARKET, BY REGION, 2022–2029 (USD MILLION) 132

TABLE 64           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          134

TABLE 65           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          134

TABLE 66           ASIA PACIFIC: IN VITRO FERTILIZATION FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          135

TABLE 67           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)         135

TABLE 68           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)           136

TABLE 69           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)          136

TABLE 70           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,

2022–2029 (USD MILLION)          137

TABLE 71           ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)          137

TABLE 72           CHINA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          138

TABLE 73           CHINA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          139

TABLE 74           CHINA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          139

TABLE 75           CHINA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       140

TABLE 76           JAPAN: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          140

TABLE 77           JAPAN: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          141

TABLE 78           JAPAN: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          141

TABLE 79           JAPAN: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       142

TABLE 80           INDIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          142

TABLE 81           INDIA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          143

TABLE 82           INDIA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          143

TABLE 83           INDIA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       144

TABLE 84           AUSTRALIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          145

TABLE 85           AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          145

TABLE 86           AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          146

TABLE 87           AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)           146

TABLE 88           SOUTH KOREA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          147

TABLE 89           SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION            147

TABLE 90           SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)         148

TABLE 91           SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA,

BY TYPE, 2022–2029 (USD MILLION)       148

TABLE 92           REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          149

TABLE 93           REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT,

BY TYPE, 2022–2029 (USD MILLION)       149

TABLE 94           REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR INCUBATORS,

BY TYPE, 2022–2029 (USD MILLION)       150

TABLE 95           REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)           150

TABLE 96           EUROPE: IN VITRO FERTILIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          151

TABLE 97           EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          152

TABLE 98          EUROPE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          152

TABLE 99           EUROPE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          153

TABLE 100         EUROPE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       153

TABLE 101         EUROPE: IN VITRO FERTILIZATION MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)          154

TABLE 102         EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,

2022–2029 (USD MILLION)          154

TABLE 103         EUROPE: IN VITRO FERTILIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)          155

TABLE 104         GERMANY: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          155

TABLE 105         GERMANY: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          156

TABLE 106         GERMANY: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          156

TABLE 107         GERMANY: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)   157

TABLE 108         UK: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     157

TABLE 109         UK: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          158

TABLE 110         UK: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          158

TABLE 111         UK: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE,

2022–2029 (USD MILLION)          159

TABLE 112         FRANCE: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          159

TABLE 113         FRANCE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          160

TABLE 114         FRANCE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          160

TABLE 115         FRANCE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       161

TABLE 116         ITALY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          161

TABLE 117         ITALY: IN VITRO FERTILIZATION FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          162

TABLE 118         ITALY: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          162

TABLE 119         ITALY: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE,

2022–2029 (USD MILLION)          163

TABLE 120         SPAIN: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          163

TABLE 121         SPAIN: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          164

TABLE 122         SPAIN: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          164

TABLE 123         SPAIN: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       165

TABLE 124         REST OF EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          165

TABLE 125         REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)           166

TABLE 126         REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)         166

TABLE 127         REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA,

BY TYPE, 2022–2029 (USD MILLION)       167

TABLE 128         NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          167

TABLE 129         NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          168

TABLE 130         NORTH AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)           168

TABLE 131         NORTH AMERICA: IN VITRO FERTILIZATION FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          169

TABLE 132         NORTH AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA,

BY TYPE, 2022–2029 (USD MILLION)       169

TABLE 133         NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)          170

TABLE 134         NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,

2022–2029 (USD MILLION)          170

TABLE 135         NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)          171

TABLE 136         US: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     172

TABLE 137         US: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          172

TABLE 138         US: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          173

TABLE 139         US: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE,

2022–2029 (USD MILLION)          173

TABLE 140         CANADA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          174

TABLE 141        CANADA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          175

TABLE 142         CANADA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          175

TABLE 143         CANADA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)   176

TABLE 144         LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          176

TABLE 145         LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          177

TABLE 146         LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)           177

TABLE 147         LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)         178

TABLE 148         LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA,

BY TYPE, 2022–2029 (USD MILLION)       178

TABLE 149         LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)          179

TABLE 150         LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE,

2022–2029 (USD MILLION)          179

TABLE 151         LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)          180

TABLE 152         BRAZIL: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          181

TABLE 153         BRAZIL: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          181

TABLE 154         BRAZIL: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          182

TABLE 155         BRAZIL: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       182

TABLE 156         MEXICO: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          183

TABLE 157         MEXICO: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE,

2022–2029 (USD MILLION)          184

TABLE 158         MEXICO: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE,

2022–2029 (USD MILLION)          184

TABLE 159         MEXICO: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)       185

TABLE 160         REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          186

TABLE 161         REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT,

BY TYPE, 2022–2029 (USD MILLION)       186

TABLE 162         REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS,

BY TYPE, 2022–2029 (USD MILLION)       187

TABLE 163         REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)  187

TABLE 164         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY REGION,

2022–2029 (USD MILLION)          188

TABLE 165         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          189

TABLE 166         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT,

BY TYPE, 2022–2029 (USD MILLION)       189

TABLE 167         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS,

BY TYPE, 2022–2029 (USD MILLION)       190

TABLE 168         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION)  190

TABLE 169         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)       191

TABLE 170         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022–2029 (USD MILLION)  191

TABLE 171         MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY END USER,

2022–2029 (USD MILLION)          192

TABLE 172         GCC COUNTRIES: IN VITRO FERTILIZATION MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          193

TABLE 173         GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION)           193

TABLE 174         GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)         194

TABLE 175         GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA,

BY TYPE, 2022–2029 (USD MILLION)       194

TABLE 176         REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        195

TABLE 177         REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022–2029 (USD MILLION) 195

TABLE 178         REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022–2029 (USD MILLION)            196

TABLE 179         REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022–2029 (USD MILLION) 196

TABLE 180         OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES             198

TABLE 181         IN VITRO FERTILIZATION MARKET: DEGREE OF COMPETITION 200

TABLE 182         IN VITRO FERTILIZATION MARKET: PRODUCT FOOTPRINT              205

TABLE 183         IN VITRO FERTILIZATION MARKET: END-USER FOOTPRINT              206

TABLE 184         IN VITRO FERTILIZATION MARKET: REGION FOOTPRINT              207

TABLE 185         IN VITRO FERTILIZATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES           210

TABLE 186         IN VITRO FERTILIZATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES  211

TABLE 187         IN VITRO FERTILIZATION MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JUNE 2024      214

TABLE 188         IN VITRO FERTILIZATION MARKET: DEALS, JANUARY 2021–JUNE 2024          214

TABLE 189         COOPERSURGICAL, INC.: COMPANY OVERVIEW             216

TABLE 190         COOPERSURGICAL, INC.: PRODUCTS OFFERED 217

TABLE 191         COOPERSURGICAL, INC.: DEALS, JANUARY 2021–JUNE 2024              218

TABLE 192         VITROLIFE: COMPANY OVERVIEW         220

TABLE 193         VITROLIFE: PRODUCTS OFFERED          221

TABLE 194         VITROLIFE: DEALS, JANUARY 2021–JUNE 2024    222

TABLE 195         COOK MEDICAL INC.: COMPANY OVERVIEW     224

TABLE 196         COOK MEDICAL INC.: PRODUCTS OFFERED      224

TABLE 197         COOK MEDICAL INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JUNE 2024           225

TABLE 198         COOK MEDICAL INC.: DEALS, JANUARY 2021–JUNE 2024 225

TABLE 199         HAMILTON THORNE: COMPANY OVERVIEW     227

TABLE 200         HAMILTON THORNE: PRODUCTS OFFERED      228

TABLE 201         HAMILTON THORNE: DEALS, JANUARY 2021–JUNE 2024 229

TABLE 202         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              231

TABLE 203         THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED              232

TABLE 204         FUJIFILM IRVINE SCIENTIFIC: COMPANY OVERVIEW     234

TABLE 205         FUJIFILM IRVINE SCIENTIFIC: PRODUCTS OFFERED      235

TABLE 206         FUJIFILM IRVINE SCIENTIFIC: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JUNE 2024           236

TABLE 207         FUJIFILM IRVINE SCIENTIFIC: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024           236

TABLE 208         KITAZATO CORPORATION: COMPANY OVERVIEW         237

TABLE 209         KITAZATO CORPORATION: PRODUCTS OFFERED         237

TABLE 210         KITAZATO CORPORATION: DEALS, JANUARY 2021–JUNE 2024              239

TABLE 211         ESCO MICRO PTE. LTD.: COMPANY OVERVIEW 240

TABLE 212         ESCO MICRO PTE. LTD.: PRODUCTS OFFERED 240

TABLE 213         ESCO MICRO PTE. LTD.: DEALS, JANUARY 2021–MARCH 2024              242

TABLE 214         FERTIPRO NV: COMPANY OVERVIEW    243

TABLE 215         FERTIPRO NV: PRODUCTS OFFERED     243

TABLE 216         GENEA BIOMEDX: COMPANY OVERVIEW           245

TABLE 217         GENEA BIOMEDX: PRODUCTS OFFERED            245

TABLE 218         GENEA BIOMEDX: DEALS, JANUARY 2021–JUNE 2024      246

TABLE 219         NIKON CORPORATION: COMPANY OVERVIEW 247

TABLE 220         NIKON CORPORATION: PRODUCTS OFFERED  248

TABLE 221         OLYMPUS: COMPANY OVERVIEW          249

TABLE 222         OLYMPUS: PRODUCTS OFFERED           250

TABLE 223         CORNING INCORPORATED: COMPANY OVERVIEW        251

TABLE 224         CORNING INCORPORATED: PRODUCTS OFFERED         252

TABLE 225         CARL ZEISS MICROSCOPY GMBH: COMPANY OVERVIEW              253

TABLE 226         CARL ZEISS MICROSCOPY GMBH: PRODUCTS OFFERED              254

TABLE 227         EPPENDORF: COMPANY OVERVIEW      255

TABLE 228         EPPENDORF: PRODUCTS OFFERED       256

TABLE 229         EPPENDORF: DEALS, JANUARY 2021–JUNE 2024 256

TABLE 230         MEIJII TECHNO: COMPANY OVERVIEW 257

TABLE 231         MEIJII TECHNO: PRODUCTS OFFERED  257

TABLE 232         LEICA MICROSYSTEMS: COMPANY OVERVIEW  258

TABLE 233         LEICA MICROSYSTEMS: PRODUCTS OFFERED   258

TABLE 234         GE HEALTHCARE: COMPANY OVERVIEW           259

TABLE 235         GE HEALTHCARE: PRODUCTS OFFERED            260

TABLE 236         GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JUNE 2024           261

TABLE 237         GE HEALTHCARE: DEALS, JANUARY 2021– JUNE 2024     261

TABLE 238         BIOIMAGER: COMPANY OVERVIEW       262

TABLE 239         ALLWIN MEDICAL DEVICES: COMPANY OVERVIEW       263

TABLE 240         SHANGHAI UNICORN MEDICAL TECHNOLOGY: COMPANY OVERVIEW        263

TABLE 241         GYNEMED: COMPANY OVERVIEW         264

TABLE 242         INVITROCARE: COMPANY OVERVIEW   265

TABLE 243         IVFTECH: COMPANY OVERVIEW            266

TABLE 244         LABIVF: COMPANY OVERVIEW 267

TABLE 245         MONASH BIOTECH: COMPANY OVERVIEW        268

TABLE 246         HUNTER SCIENTIFIC: COMPANY OVERVIEW     268

TABLE 247         CALIBRE SCIENTIFIC: COMPANY OVERVIEW     269

TABLE 248         SHIVANI SCIENTIFIC INDUSTRIES (P) LTD.: COMPANY OVERVIEW        270

TABLE 249         MINITUBE HUMAN ART: COMPANY OVERVIEW 271

LIST OF FIGURES

FIGURE 1           IN VITRO FERTILIZATION MARKET SEGMENTATION    28

FIGURE 2           IN VITRO FERTILIZATION MARKET: RESEARCH DESIGN              31

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION    36

FIGURE 5           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  37

FIGURE 6           IN VITRO FERTILIZATION MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION        38

FIGURE 7           IN VITRO FERTILIZATION MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH           39

FIGURE 8           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   40

FIGURE 9           DATA TRIANGULATION             41

FIGURE 10         GROWTH RATE ASSUMPTIONS 43

FIGURE 11         IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)     45

FIGURE 12         IN VITRO FERTILIZATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 46

FIGURE 13         IN VITRO FERTILIZATION MARKET, BY REGION, 2024–2029              47

FIGURE 14         RISING INFERTILITY RATES AND EMERGENCE OF IVF PROCEDURES WORLDWIDE TO DRIVE MARKET             48

FIGURE 15         ASIA PACIFIC TO LEAD MARKET IN 2024             49

FIGURE 16         CHINA AND FERTILITY CLINICS & IVF CENTERS SEGMENT DOMINATED MARKET

IN 2023 50

FIGURE 17         CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD              51

FIGURE 18         IN VITRO FERTILIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES        53

FIGURE 19         IN VITRO FERTILIZATION MARKET: VALUE CHAIN ANALYSIS              64

FIGURE 20         REVENUE SHIFT AND NEW REVENUE POCKETS 65

FIGURE 21         AVERAGE SELLING PRICE TREND OF IVF EQUIPMENT, BY REGION,

2023 (USD THOUSAND) 66

FIGURE 22         AVERAGE SELLING PRICE OF TOP 3 ACCESSORIES, BY KEY PLAYER, 2023 (USD)      68

FIGURE 23         PORTER’S FIVE FORCES ANALYSIS         69

FIGURE 24         PATENT ANALYSIS, JANUARY 2013– DECEMBER 2023      71

FIGURE 25         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS   77

FIGURE 26         KEY BUYING CRITERIA, BY TOP TWO END USERS           78

FIGURE 27         IN VITRO FERTILIZATION MARKET: ECOSYSTEM ANALYSIS              80

FIGURE 28         IN VITRO FERTILIZATION MARKET: SUPPLY CHAIN ANALYSIS              82

FIGURE 29         INVESTMENT AND FUNDING SCENARIO, 2018–2022       90

FIGURE 30         NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022              90

FIGURE 31         VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)          91

FIGURE 32         ASIA PACIFIC: IN VITRO FERTILIZATION MARKET SNAPSHOT              133

FIGURE 33         REVENUE ANALYSIS OF TOP PLAYERS IN IN VITRO FERTILIZATION MARKET,

2019–2023 (USD MILLION)          199

FIGURE 34         MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023          200

FIGURE 35         RANKING OF KEY PLAYERS IN IN VITRO FERTILIZATION MARKET, 2023  202

FIGURE 36         IN VITRO FERTILIZATION MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023     203

FIGURE 37         IN VITRO FERTILIZATION MARKET: COMPANY FOOTPRINT              204

FIGURE 38         IN VITRO FERTILIZATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023           209

FIGURE 39         EV/EBITDA OF KEY VENDORS   212

FIGURE 40         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS          212

FIGURE 41         IN VITRO FERTILIZATION MARKET: BRAND/PRODUCT COMPARISON   213

FIGURE 42         COOPERSURGICAL, INC.: COMPANY SNAPSHOT (2023) 216

FIGURE 43         VITROLIFE: COMPANY SNAPSHOT (2023)           221

FIGURE 44         HAMILTON THORNE: COMPANY SNAPSHOT (2023)       228

FIGURE 45         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)   232

FIGURE 46         FUJIFILM IRVINE SCIENTIFIC: COMPANY SNAPSHOT (2023)              234

FIGURE 47         NIKON CORPORATION: COMPANY SNAPSHOT (2023)   247

FIGURE 48         OLYMPUS: COMPANY SNAPSHOT (2023)            249

FIGURE 49         CORNING INCORPORATED: COMPANY SNAPSHOT (2023)              252

FIGURE 50         CARL ZEISS MICROSCOPY GMBH: COMPANY SNAPSHOT (2022)              254

FIGURE 51         EPPENDORF: COMPANY SNAPSHOT (2023)        255

FIGURE 52         GE HEALTHCARE: COMPANY SNAPSHOT (2023)             260

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧